CD25 expression change and response to treatment
Patient no. . | CD25pre . | CD25post . | Clinical response . |
|---|---|---|---|
| 1 | 50 | 31 | Partial |
| 2 | 2 | 23 | None |
| 3 | 14 | 28 | Complete |
| 4 | 33 | 45 | Complete |
| 5 | 61 | 60 | None |
| 6 | 11 | 40 | Complete |
| 7 | 5 | 50 | None |
| 8 | 6 | 18 | Complete |
| 9 | 13 | 18 | Partial |
| 10 | ND | ND | Not evaluable |
| 11 | 14 | 14 | Partial |
| 12 | 56 | ND | Partial |
| 13 | 60 | 61 | None |
| 14 | 4 | 16 | Not evaluable |
Patient no. . | CD25pre . | CD25post . | Clinical response . |
|---|---|---|---|
| 1 | 50 | 31 | Partial |
| 2 | 2 | 23 | None |
| 3 | 14 | 28 | Complete |
| 4 | 33 | 45 | Complete |
| 5 | 61 | 60 | None |
| 6 | 11 | 40 | Complete |
| 7 | 5 | 50 | None |
| 8 | 6 | 18 | Complete |
| 9 | 13 | 18 | Partial |
| 10 | ND | ND | Not evaluable |
| 11 | 14 | 14 | Partial |
| 12 | 56 | ND | Partial |
| 13 | 60 | 61 | None |
| 14 | 4 | 16 | Not evaluable |
Italicized text indicates up-regulation of IL-2R. ND indicates specimen not available.